Christopher Michael Cashman

Christopher Michael Cashman is the founder of Protez Pharmaceuticals, Inc. which was founded in 2003.
He is currently the Chairman at MBF Therapeutics, Inc., Director at Phoenix S&T, Inc., University City Science Center, Life Sciences Pennsylvania, Science Center of Iowa, Noble Biomaterials, Inc., Greater Philadelphia Life Sciences Congress, and Polycore Therapeutics, Inc. He is also an Advisor at Grays Ferry GP, LLC.
Mr. Cashman's former positions include President, Chief Executive Officer & Director at Marinus Pharmaceuticals, Inc., President & Chief Executive Officer at Message Pharmaceuticals, Inc., Director at Rapid Micro Biosystems, Inc., Director at JDP Therapeutics LLC, Director at Locus Pharmaceuticals, Inc., Vice President-Sales & Marketing at Pfizer Inc. and Smithkline Beecham Plc, and Principal at Quaker Partners LLC.
Mr. Cashman has a graduate degree from Purdue University and an undergraduate degree from the University of Minnesota.